Significados de advanced pd em inglês

We performed separate analyses for patients with early and advanced PD.

Conclusion: STN-S is an effective therapeutic option in advanced PD.

Our experience confirms the robust antiparkinsonian effect of DBS of the STN in advanced PD.

The clinical experience with cell replacement therapy for advanced PD has yielded notable successes and failures.

In advanced PD patients, switching from a pulsatile to continuous dopaminergic delivery may widen patients' therapeutic window.

Methods: Forty-two patients with advanced PD consecutively treated with bilateral STN stimulation using multi-channel microelectrode recording were included in this study.

Objectives: to assess the effect of STN stimulation on cerebral activation during actual and imagined movement in patients with advanced PD.

Interpretation: Rivastigmine may represent a new therapeutic option for moderate to severe apathy in advanced PD patients with optimised dopaminergic treatment and without depression dementia.

We sought to establish whether rivastigmine's ability to inhibit acetyl- and butyrylcholinesterases could relieve the symptoms of apathy in dementia-free, non-depressed patients with advanced PD.

Of 39 patients with advanced PD meeting CAPSIT criteria for STN-S, 23 underwent surgery; 16 patients decided against surgery and continued on drug schedule adjustments.